JO
ALBO

John Overdeck’s Albireo Pharma Inc ALBO Stock Holding History

John Overdeck’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-54,292
Closed -$39.4M – 4885
2021
Q2 		$39.4M Sell
54,292
-147,323
-73% -$4.79M 0.09% 264
2021
Q1 		$7.11M Sell
201,615
-44,139
-18% -$1.63M 0.02% 866
2020
Q4 		$9.22M Buy
245,754
+90,696
+58% +$3.3M 0.03% 631
2020
Q3 		$5.17M Buy
155,058
+119,076
+331% +$3.47M 0.02% 782
2020
Q2 		$953K Buy
35,982
+4,251
+13% +$100K ﹤0.01% 1570
2020
Q1 		$519K Sell
31,731
-5,523
-15% -$121K ﹤0.01% 1900
2019
Q4 		$947K Buy
37,254
+3,903
+12% +$78.1K ﹤0.01% 2232
2019
Q3 		$667K Buy
33,351
+10,567
+46% +$274K ﹤0.01% 2321
2019
Q2 		$735K Buy
+22,784
New +$762K ﹤0.01% 2202
2018
Q3 		– Sell
-30,443
Closed -$1.08M – 3717
2018
Q2 		$1.08M Buy
+30,443
New +$986K ﹤0.01% 2093
2014
Q2 		– Sell
-1,078
Closed -$88K – 2402
2014
Q1 		$88K Sell
1,078
-2,270
-68% -$207K ﹤0.01% 1896
2013
Q4 		$231K Buy
+3,348
New +$245K ﹤0.01% 1967

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

John Overdeck's ALBO Position: Q3 2021 in Review

John Overdeck sold out of Albireo Pharma Inc (ALBO) in Q3 2021, closing a stake of 54,292 shares — an estimated $39.4M sold.

John Overdeck first reported a position in ALBO in Q4 2013 and held it in 12 quarters. The position peaked at $39.4M in Q2 2021. 94 funds tracked by Wall St. Rank hold ALBO as of Q3 2021.

  • John Overdeck reported no remaining Albireo Pharma Inc position as of Q3 2021 after selling out during the quarter.
  • John Overdeck sold 54,292 Albireo Pharma Inc shares in Q3 2021, an estimated $39.4M.
  • John Overdeck first reported a position in Albireo Pharma Inc in Q4 2013 and held it in 12 quarters.
  • John Overdeck's Albireo Pharma Inc position peaked at $39.4M in Q2 2021.
  • 94 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2021.

Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.